
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6236288
[patent_doc_number] => 20100267635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'USE OF PROTEASE INHIBITORS AND GRF MOLECULES IN COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/763978
[patent_app_country] => US
[patent_app_date] => 2010-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9932
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267635.pdf
[firstpage_image] =>[orig_patent_app_number] => 12763978
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/763978 | USE OF PROTEASE INHIBITORS AND GRF MOLECULES IN COMBINATION THERAPY | Apr 19, 2010 | Abandoned |
Array
(
[id] => 6236289
[patent_doc_number] => 20100267636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'USE OF CYTOCHROME P450-METABOLIZED DRUGS AND GRF MOLECULES IN COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/764007
[patent_app_country] => US
[patent_app_date] => 2010-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10335
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267636.pdf
[firstpage_image] =>[orig_patent_app_number] => 12764007
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/764007 | USE OF CYTOCHROME P450-METABOLIZED DRUGS AND GRF MOLECULES IN COMBINATION THERAPY | Apr 19, 2010 | Abandoned |
Array
(
[id] => 6502482
[patent_doc_number] => 20100260669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System'
[patent_app_type] => utility
[patent_app_number] => 12/761297
[patent_app_country] => US
[patent_app_date] => 2010-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 33790
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260669.pdf
[firstpage_image] =>[orig_patent_app_number] => 12761297
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/761297 | Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System | Apr 14, 2010 | Abandoned |
Array
(
[id] => 4639725
[patent_doc_number] => 08017752
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-09-13
[patent_title] => 'Soluble epidermal growth factor receptor isoforms'
[patent_app_type] => utility
[patent_app_number] => 12/731387
[patent_app_country] => US
[patent_app_date] => 2010-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19563
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/017/08017752.pdf
[firstpage_image] =>[orig_patent_app_number] => 12731387
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/731387 | Soluble epidermal growth factor receptor isoforms | Mar 24, 2010 | Issued |
Array
(
[id] => 6236232
[patent_doc_number] => 20100267620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'METHODS FOR SLOWING SENESCENCE AND TREATING AND PREVENTING DISEASES ASSOCIATED WITH SENESCENCE'
[patent_app_type] => utility
[patent_app_number] => 12/728891
[patent_app_country] => US
[patent_app_date] => 2010-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16355
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267620.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728891
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728891 | METHODS FOR SLOWING SENESCENCE AND TREATING AND PREVENTING DISEASES ASSOCIATED WITH SENESCENCE | Mar 21, 2010 | Abandoned |
Array
(
[id] => 6339973
[patent_doc_number] => 20100247530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING PRESBYCUSIS'
[patent_app_type] => utility
[patent_app_number] => 12/727902
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13982
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12727902
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/727902 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING PRESBYCUSIS | Mar 18, 2010 | Abandoned |
Array
(
[id] => 7756709
[patent_doc_number] => 20120028906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'METHOD FOR AFFECTING THE TIMING OF CERVICAL RIPENING AND FOR PARTURITION'
[patent_app_type] => utility
[patent_app_number] => 13/146192
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2982
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028906.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146192
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146192 | METHOD FOR AFFECTING THE TIMING OF CERVICAL RIPENING AND FOR PARTURITION | Mar 9, 2010 | Abandoned |
Array
(
[id] => 6499634
[patent_doc_number] => 20100209956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 12/721474
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 46190
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209956.pdf
[firstpage_image] =>[orig_patent_app_number] => 12721474
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/721474 | METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION | Mar 9, 2010 | Abandoned |
Array
(
[id] => 7807984
[patent_doc_number] => 20120058938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'NUTRITIONAL COMPOSITION INDUCING A POSTPRANDIAL ENDOCRINE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 13/255477
[patent_app_country] => US
[patent_app_date] => 2010-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12338
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058938.pdf
[firstpage_image] =>[orig_patent_app_number] => 13255477
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/255477 | NUTRITIONAL COMPOSITION INDUCING A POSTPRANDIAL ENDOCRINE RESPONSE | Mar 8, 2010 | Abandoned |
Array
(
[id] => 8363680
[patent_doc_number] => 08252744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Implantable pump for protein delivery for obesity control by drug infusion into the brain'
[patent_app_type] => utility
[patent_app_number] => 12/709920
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9702
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12709920
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/709920 | Implantable pump for protein delivery for obesity control by drug infusion into the brain | Feb 21, 2010 | Issued |
Array
(
[id] => 5958962
[patent_doc_number] => 20110183349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'BIOMARKERS FOR IgA NEPHROPATHY AND APPLICATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/695907
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 7399
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183349.pdf
[firstpage_image] =>[orig_patent_app_number] => 12695907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/695907 | Serpine2 as a biomarker for IgA nephropathy | Jan 27, 2010 | Issued |
Array
(
[id] => 6504268
[patent_doc_number] => 20100260767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Composition and Method for Treating Inflammatory Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/687981
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25953
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260767.pdf
[firstpage_image] =>[orig_patent_app_number] => 12687981
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/687981 | Composition and Method for Treating Inflammatory Disorders | Jan 14, 2010 | Abandoned |
Array
(
[id] => 6487351
[patent_doc_number] => 20100285564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Anticalins'
[patent_app_type] => utility
[patent_app_number] => 12/654809
[patent_app_country] => US
[patent_app_date] => 2010-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15730
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285564.pdf
[firstpage_image] =>[orig_patent_app_number] => 12654809
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/654809 | Anticalins | Jan 4, 2010 | Issued |
Array
(
[id] => 6423878
[patent_doc_number] => 20100168025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Stroke-generated angiogenesis enhancers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/655503
[patent_app_country] => US
[patent_app_date] => 2009-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11336
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12655503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/655503 | Treatment of stroke using domain V of perlecan | Dec 30, 2009 | Issued |
Array
(
[id] => 6280187
[patent_doc_number] => 20100119482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Treatment of Conditions Through Modulation of the Autonomic Nervous System During at Least One Predetermined Menstrual Cycle Phase'
[patent_app_type] => utility
[patent_app_number] => 12/647247
[patent_app_country] => US
[patent_app_date] => 2009-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31684
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119482.pdf
[firstpage_image] =>[orig_patent_app_number] => 12647247
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647247 | Treatment of Conditions Through Modulation of the Autonomic Nervous System During at Least One Predetermined Menstrual Cycle Phase | Dec 23, 2009 | Abandoned |
Array
(
[id] => 6289770
[patent_doc_number] => 20100158880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'REGENERATION AND REPAIR OF NEURAL TISSUE FOLLOWING INJURY'
[patent_app_type] => utility
[patent_app_number] => 12/642773
[patent_app_country] => US
[patent_app_date] => 2009-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 41451
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158880.pdf
[firstpage_image] =>[orig_patent_app_number] => 12642773
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/642773 | REGENERATION AND REPAIR OF NEURAL TISSUE FOLLOWING INJURY | Dec 18, 2009 | Abandoned |
Array
(
[id] => 6431907
[patent_doc_number] => 20100143442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'GROWTH FACTOR COMPLEXES AND MODULATION OF CELL MIGRATION AND GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/627647
[patent_app_country] => US
[patent_app_date] => 2009-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 15451
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143442.pdf
[firstpage_image] =>[orig_patent_app_number] => 12627647
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/627647 | GROWTH FACTOR COMPLEXES AND MODULATION OF CELL MIGRATION AND GROWTH | Nov 29, 2009 | Abandoned |
Array
(
[id] => 8189250
[patent_doc_number] => 08183205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Granulocyte colony stimulating factor for the treatment of an ovulation disorder caused by luteinized unruptured follicle'
[patent_app_type] => utility
[patent_app_number] => 12/615035
[patent_app_country] => US
[patent_app_date] => 2009-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2556
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183205.pdf
[firstpage_image] =>[orig_patent_app_number] => 12615035
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/615035 | Granulocyte colony stimulating factor for the treatment of an ovulation disorder caused by luteinized unruptured follicle | Nov 8, 2009 | Issued |
Array
(
[id] => 7586412
[patent_doc_number] => 20110280922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'DEVICES AND METHODS FOR TREATING AND/OR PREVENTING DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/063887
[patent_app_country] => US
[patent_app_date] => 2009-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17591
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20110280922.pdf
[firstpage_image] =>[orig_patent_app_number] => 13063887
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063887 | DEVICES AND METHODS FOR TREATING AND/OR PREVENTING DISEASES | Nov 8, 2009 | Abandoned |
Array
(
[id] => 6228879
[patent_doc_number] => 20100183617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'COMPOSITIONS AND METHODS FOR REGULATING SAS1R'
[patent_app_type] => utility
[patent_app_number] => 12/613947
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 46187
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183617.pdf
[firstpage_image] =>[orig_patent_app_number] => 12613947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/613947 | COMPOSITIONS AND METHODS FOR REGULATING SAS1R | Nov 5, 2009 | Abandoned |